// App-Quantinova.ai

Mo1296 : Quality of Life for Patients With Deep Remission vs. Clinical Remission and Deep Remission vs. Absence of Mucosal Ulceration: 3-Year Data From CHARM/ADHERE

Researchers

Presenter

  • Remo Panaccione

Principal Investigators

  • Edouard Louis

  • Martha Skup

  • Mei Yang

  • Paul F. Pollack

  • Roopal Thakkar

  • Anne A. Camez

  • Jingdong Chao

  • Parvez Mulani

  • William Sandborn

Medical Centers

  • University of Liege and CHU Liege, Liege, Belgium

  • Centre Hospitalier Universitaire de Lille, Hopital Claude Huriez, Lille, France

  • University of California, San Diego, La Jolla, CA

  • University of Calgary, Calgary, AB, Canada

Locations

  • France

  • Canada

  • United States

  • Belgium

Companies

  • Abbott

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory bowel disease

  • Crohn's disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

Outcome

  • N/A


Study Design

  • open label

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim